Precision Medicine for CLL

Jennifer Brown, MD, PhD
Video Categories: Personalized Medicine

Dr. Jennifer R. Brown deliberates on the state of personalized medicine in relation to CLL. She explains that the targeted drugs currently used for CLL actually work for most patients, rather than just a subgroup. Also, CLL therapies are now generally in pill form and well tolerated with few side effects.
September 20, 2013

Demonstrating the Value of Personalized Medicine

Jayson Slotnik provides an overview of the issues in demonstrating the value of personalized medicine tests and products

October 16, 2015

Pembrolizumab vs. Ipilimumab

Dr. Sanjiv Agarwala discusses the pros and cons of using Pembrolizumab over anti-CTLA4 antibody therapy.